KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

April 17, 2025 at 21:03 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	272.26	-0.39 (-0.14%)
AAPL	312.41	+1.41 (0.45%)
AMD	489.28	+7.23 (1.50%)
BAC	63.00	-0.25 (-0.40%)
GOOG	356.62	-3.51 (-0.97%)
META	589.90	+1.13 (0.19%)
MSFT	499.86	+12.40 (2.54%)
NVDA	218.99	-0.23 (-0.10%)
ORCL	143.47	-0.92 (-0.64%)
TSLA	319.53	-2.02 (-0.63%)

Symbol

Price

Change (%)

AMZN

272.26

-0.39 (-0.14%)

AAPL

312.41

+1.41 (0.45%)

AMD

489.28

+7.23 (1.50%)

BAC

63.00

-0.25 (-0.40%)

GOOG

356.62

-3.51 (-0.97%)

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Contacts

More News

Recent Quotes

Starting at /week.